Christiana Stamoulis joined Incyte as Executive Vice President and Chief Financial Officer in 2019. With over 20 years of experience in the biotechnology industry, Ms. Stamoulis came to Incyte from Unum Therapeutics, where she was President and Chief Financial Officer. Prior to Unum, she was the Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals. Before joining Vertex, Ms. Stamoulis spent nearly 15 years in the investment banking and management consulting industries as a Managing Director at Citigroup’s Investment Banking division and a Senior Investment Banker in the Healthcare Investment Banking Group at Goldman Sachs. She began her career as a strategy consultant at The Boston Consulting Group. Ms. Stamoulis earned two Bachelors of Science from the Massachusetts Institute of Technology (MIT) and a Master of Business Administration from the MIT Sloan School of Management. Ms. Stamoulis currently serves on the board of directors of Hologic.